Extend

Extend is a National Technology Transfer Hub established by CDP Venture Capital SGR through its Technology Transfer Fund, focusing on the biopharmaceutical sector. The initiative aims to identify novel targets and therapeutic approaches by transforming research outcomes into innovative companies. Collaborating with Evotec and Angelini Ventures, Extend brings together leading universities, research centers, and venture capital funds to foster the competitive development of the biotech sector in Italy.

The hub operates with a funding target of €30 million, seeking to support the best initiatives originating from the national research system. It focuses on therapeutic areas with high unmet medical needs, including oncology, central nervous system disorders, and rare diseases. By investing in proof-of-concept projects and seed-stage startups, Extend aims to bridge the gap between academic research and market applications, facilitating the commercialization of scientific innovations.

Extend's strategic approach involves a multidisciplinary platform that combines academic innovation with industry expertise. By leveraging the strengths of its partners and co-investors, the hub strives to enhance the development and market access of promising biotech initiatives, contributing to the growth and competitiveness of the Italian biopharmaceutical industry.